Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
05/2012
05/17/2012US20120121623 Novel antipathogenic peptides
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121595 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsp90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
05/17/2012US20120121590 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)
05/17/2012US20120121574 Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore
05/17/2012US20120121543 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
05/17/2012US20120121507 Peptide ligands for clusterin and uses thereof
05/16/2012EP2452947A1 Viral infection enhancing peptide
05/16/2012EP2452653A1 cRGD peptide derivative and its manufacture and implant having a coating containing a cRGD peptide derivative
05/16/2012CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/16/2012CN102459322A 用于免疫治疗的HLA-B<sup>*</sup>0702共有表位的鉴定、优化与应用 HLA-B for immunotherapy <sup> * </ sup> 0702 total epitope identification, optimization and application
05/16/2012CN102459321A 酪蛋白来源的蛋白酶抑制肽 Casein-derived protease inhibitory peptide
05/16/2012CN102459314A Ttk peptides and vaccines including the same
05/16/2012CN102459313A High penetration prodrug compositions of peptides and peptide-related compounds
05/16/2012CN102459312A Melanocortin receptor-specific peptides
05/16/2012CN102459311A 神经调节肽u衍生物 Neuromedin derivative u
05/16/2012CN102459310A Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
05/16/2012CN102459309A Bleaching peptide hydrolysate proteasome activator and compositions containing same
05/16/2012CN102458438A 具有肽骨架和c-末端修饰的经修饰补体抑素 Somatostatin has modified the peptide backbone complement and c- terminal modification of
05/16/2012CN102453079A Peptide specifically binding basic fibroblast growth factor receptor
05/16/2012CN101747415B Rabbit anti-human MARVELD1 peptide polyclonal antibody and preparation method thereof
05/15/2012US8178657 Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178650 Cyclic depsipeptides
05/15/2012US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2638854C Pcr hot start by magnesium sequestration
05/15/2012CA2529449C Pharmaceutical composition comprising cyclic somatostatin analogues
05/15/2012CA2511755C 1-desamino-8-d-arginyl vasopressin analogs
05/15/2012CA2501188C Combinatorial protein library screening by periplasmic expression
05/15/2012CA2335098C Protease susceptibility ii
05/10/2012WO2012061662A1 Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors
05/10/2012WO2012061113A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
05/10/2012WO2012061082A2 Chromobacterium bioactive compositions and metabolites
05/10/2012WO2012060480A1 Antigen peptide for suppressing metastasis, anti-metastatic vaccine including same, composition for suppressing and treating metastasis, and method for screening metastasis-related target materials and metastasis suppressant
05/10/2012WO2012031103A3 Inhibitors of bcl-2
05/10/2012WO2012026309A9 Creation of anti-pad4 antibody pharmaceutical
05/10/2012WO2012023781A3 Peptide having anti-red tide activities, and use thereof
05/10/2012WO2012012352A3 Modified peptides and proteins
05/10/2012US20120115794 Use of cd44v6 in the treatment of ophthalmic diseases
05/10/2012US20120115793 Peptidomimetic macrocycles
05/10/2012US20120115789 Methylglyoxal-Scavenging Compounds and Their Use for the Prevention and Treatment of Pain and/or Hyperalgesia
05/10/2012US20120115785 Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity
05/10/2012US20120115783 Peptidomimetic macrocycles
05/10/2012US20120115221 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
05/10/2012US20120115168 Bioassay and peptides for use therein
05/10/2012US20120115164 Mammalian cytokines; related reagents
05/10/2012US20120115163 Marked peptides and use thereof for assaying circulating irap
05/10/2012US20120115136 Pna diagnostic use
05/10/2012US20120114682 Peptides for binding fibrinogen and fibrin
05/10/2012US20120114679 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/10/2012US20120114617 Peptide promoting cell adhesion and migration
05/10/2012US20120114577 Peptide Having Activity of Transforming Growth Factor and Production Method Therefor
05/10/2012US20120114565 Compounds modulators of vegf activity and uses thereof
05/10/2012CA2815789A1 Chromobacterium bioactive compositions and metabolites
05/09/2012EP2450365A1 T-cell death-inducing epitopes
05/09/2012EP2450364A1 Process for production of peptide thioester
05/09/2012EP2448965A1 Multimeric peptide conjugates and uses thereof
05/09/2012EP2448958A1 Human milk peptides
05/09/2012EP2448957A2 Methods and compositions for affecting the differentiation of clostridia in culture
05/09/2012EP2448956A1 Solid phase peptide synthesis of peptide alcohols
05/09/2012EP2303916B1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles
05/09/2012EP1979375B9 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
05/09/2012EP1368064B1 Synthesis of tetradentate peptide-chelate conjugates for colorectal cancer diagnosis
05/09/2012CN102449481A peptide ligands for isolation and treatment of autoimmune t-cells
05/09/2012CN102448988A Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
05/09/2012CN102448980A C6orf167 peptides and vaccines containing the same
05/09/2012CN102443050A Method for purifying cyclic lipopeptide compound or salt thereof
05/09/2012CN102443049A Method for synthesizing monopegylation fixed point modification thymopoietin
05/09/2012CN101691394B Method for solid phase synthesis of bitter gourd MC-JJ6 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6 peptide analogs
05/09/2012CN101555272B Solid phase preparation method of carbetocin
05/09/2012CN101503458B Small molecule polypeptide for preventing and treating angiogenesis and use thereof
05/08/2012US8173774 Polypeptides and use thereof
05/08/2012US8173770 Intermediates for LHRH antagonist synthesis, process for the production, and process for LHRH antagonist production
05/08/2012US8173768 Peptides having antimicrobial and neurotrophic activity and uses thereof
05/08/2012US8173600 Caspase-2 inhibitors and their biological applications
05/08/2012CA2266859C Colostrinin, and uses thereof
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012WO2012057713A1 Antimicrobial peptides
05/03/2012WO2012055905A1 Process for the manufacture of degarelix and its intermediates
05/03/2012WO2012055903A1 Process for the manufacture of degarelix and its intermediates
05/03/2012WO2012019192A3 Cell-permeable molecules as growth factor receptor antagonists
05/03/2012WO2012002762A3 Peptide for the treatment or prevention of allergic diseases
05/03/2012US20120108525 Methods and Compositions for the Treatment of Gastrointestinal Disorders
05/03/2012US20120108521 Immunostimulatory compositions and uses thereof
05/03/2012US20120108520 Antimicrobial Compounds and Formulations
05/03/2012US20120108519 Neo-tryptophan
05/03/2012US20120108504 Leptin agonist and methods of use
05/03/2012US20120108502 Novel anti-parasitic compounds
05/03/2012US20120108496 Short-chain peptides as parathyroid hormone (pth) receptor agonist
05/03/2012US20120108494 Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof
05/03/2012US20120108492 Ligand-specific non-antibody compounds that inhibit cr2 activation and methods of use thereof
05/03/2012US20120108450 Receptors Useful for Gas Phase Chemical Sensing
05/03/2012US20120107932 Prrs-virus receptor and its inhibitor
05/03/2012US20120107869 Organic compounds
05/03/2012US20120107800 Cell-targeting nanoparticles and uses thereof
05/03/2012US20120107335 Synthetic Oligopeptides Designed From Mite Cysteine Proteases and Methods for the Production of
05/03/2012US20120107333 Vangl1 peptides and vaccines including the same
05/03/2012US20120107322 Immunogenic and therapeutic compositions for streptococcus pyogenes
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 423